Companies
RISE Research Institutes
R&D pipelines — Continuous thermostabilization lines.
- Country
- Sweden
Coverage
| CN | EU | US | |
|---|---|---|---|
| cellulose-lignin | ✓ | ✓ | ✓ |
Regulatorsepafdanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | 3.7 billion SEK in R&D funding/grants (as of 2024) | bolagsradar.se |
| Capacity | Pilot-scale capacity for chemical and pharmaceutical processes, including reactors up to 100 liters and continuous processing systems | ri.se |
| Certification | ISO 17025 accreditation, GMP-compliant, and GLP-certified laboratories | ri.se |
| Regulatory approval | Supports regulatory alignment and documentation for EMA/FDA and CMC requirements | ri.se |
| Production site | Includes facilities in Gothenburg, Stockholm, Borås, and Örnsköldsvik (RISE Processum) | ri.se |
| Headcount | Approximately 2,300 to 3,300 employees | bolagsradar.se · show-project.eu |
| Revenue | Approximately 3.8 billion to 4.3 billion SEK annually (as of 2023-2024) | bolagsradar.se |
Independent sources: bolagsradar.se · ri.se · show-project.eu
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Lignin carbon fibers | cellulose-lignin | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.